PRKX Polyclonal Antibody

PRKX (protein kinase, X-linked) encodes a serine threonine protein kinase that has similarity to the catalytic subunit of cyclic AMP dependent protein kinases. The encoded protein is developmentally regulated and may be involved in renal epithelial morphogenesis. This protein may also be involved in macrophage and granulocyte maturation. Abnormal recombination between PRKX and a related pseudogene on chromosome Y is a frequent cause of sex reversal disorder in XX males and XY females. Pseudogenes of PRKX are found on chromosomes X, 15 and Y.

The PRKX Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of PRKX protein expression in various biological samples. This antibody is produced using state-of-the-art techniques, ensuring high affinity and specificity towards the target protein.

The PRKX Polyclonal Antibody exhibits exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. It enables researchers to accurately quantify and visualize PRKX protein expression in tissues, cells, and other biological specimens.

With its superior sensitivity, this antibody allows for the detection of low abundance PRKX protein levels, making it an invaluable tool for studying the role of PRKX in various physiological and pathological processes. Its versatility and reliability make it suitable for use in both basic research and clinical applications.

The PRKX Polyclonal Antibody is manufactured under stringent quality control standards, ensuring consistent and reproducible results. It is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming and complex antibody preparation procedures.

In summary, the PRKX Polyclonal Antibody is a highly reliable and efficient tool for the detection and analysis of PRKX protein expression. Its exceptional sensitivity, specificity, and versatility make it an indispensable asset for researchers and clinicians alike, facilitating advancements in the understanding and treatment of PRKX-related disorders.